Online CME / CE Programs
Cardiology
Present and novel approaches to treating heart failure with reduced ejection fraction (HFrEF): Where to start and next-line strategies (Michelle Kittleson MD, PhD) Released: 05/06/2022 - Expires: 05/06/2024 (1 hr CE) ACCME ACPE MOC
First and later line treatments for familial hypercholesterolemia (FH): Lowering lipids and getting to goal (Nicholas Marston MD, MPH) Released: 01/11/2022 - Expires: 01/11/2024 (1 hr CE) ACCME ACPE MOC
Transthyretin amyloidosis (ATTR): Prompt diagnosis, contemporary management strategies, and their impact on patient outcomes (Kourosh Rezania MD) Released: 12/29/2021 - Expires: 12/29/2023 (1 hr CE) ACCME ACPE MOC
Reducing vascular events and disease progression in type 2 diabetes (T2DM) and optimizing delivery of care (Matt Budoff M.D., FACC) Released: 12/16/2021 - Expires: 12/16/2023 (1.5 hr CE) ACCME ACPE MOC
The Cholesterol Wars: Navigating a Shifting Battlefield: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Multiple Faculty ) Released: 11/22/2022 - Expires: 11/22/2023 (1 hr CE) ACCME ACPE
The Cholesterol Wars: Navigating a Shifting Battlefield: The Critical Importance of Lowering LDL-C in High-Risk Patients (Multiple Faculty ) Released: 11/22/2022 - Expires: 11/22/2023 (1 hr CE) ACCME ACPE
The Cholesterol Wars: Navigating a Shifting Battlefield: Recent Cholesterol Guidelines and Integration into Clinical Practice (Multiple Faculty ) Released: 11/22/2022 - Expires: 11/22/2023 (1 hr CE) ACCME ACPE
The Cholesterol Wars: Navigating a Shifting Battlefield: Current Treatments for LDL Lowering - and Why Patient Access Is Important (Multiple Faculty ) Released: 11/22/2022 - Expires: 11/22/2023 (1 hr CE) ACCME ACPE
Hereditary transthyretin amyloidosis (ATTR) treatment strategies: best practices and emerging therapies (Michelle Kaku MD) Released: 07/02/2021 - Expires: 07/01/2023 (1 hr CE) ACCME ACPE
Managing Anticoagulated Patients with Obesity: Focus on Direct Oral Anticoagulants (NATF; online) (Multiple Faculty ) Released: 05/09/2022 - Expires: 05/08/2023 (2 hr CE) ACCME ACPE
5th Right Heart Symposium: Part 1 (NATF; online) (Multiple Faculty ) Released: 05/04/2022 - Expires: 05/03/2023 (2.25 hr CE) ACCME ACPE MOC
5th Right Heart Symposium: Part 2 (NATF; online) (Multiple Faculty ) Released: 05/04/2022 - Expires: 05/03/2023 (3.25 hr CE) ACCME ACPE MOC
5th Right Heart Symposium: Part 3 (NATF; online) (Multiple Faculty ) Released: 05/04/2022 - Expires: 05/03/2023 (3.75 hr CE) ACCME ACPE MOC
5th Right Heart Symposium: Part 4 (NATF; online) (Multiple Faculty ) Released: 05/04/2022 - Expires: 05/03/2023 (3.75 hr CE) ACCME ACPE MOC
Living in a Post-Pandemic World: What Medicine Has Learned in the Last Year (NATF; online) (Multiple Faculty ) Released: 05/04/2022 - Expires: 05/03/2023 (2.25 hr CE) ACCME ACPE MOC
The United States CTEPH Proceedings 2021, Part 2 (NATF; online) (Multiple Faculty ) Released: 12/15/2021 - CME EXPIRED: 12/14/2022
The United States CTEPH Proceedings 2021, Part 1 (NATF; online) (Multiple Faculty ) Released: 12/15/2021 - CME EXPIRED: 12/14/2022
The United States CTEPH Proceedings 2021, Part 3 (NATF; online) (Multiple Faculty ) Released: 12/15/2021 - CME EXPIRED: 12/14/2022
Advances in the management of Fabry disease (Virginia Kimonis M.D., MRCP ) Released: 08/13/2020 - CME EXPIRED: 08/13/2022
Transthyretin amyloidosis (ATTR) and its complications: Optimizing management strategies (Robert Chilton MD) Released: 06/13/2020 - CME EXPIRED: 06/13/2022
Treatment strategies in Fabry disease (William Wilcox MD) Released: 09/04/2019 - CME EXPIRED: 09/04/2021
Updates in the pharmacotherapeutic management of familial hypercholesterolemia (FH): present and emerging treatment options (John A. Tayek MD) Released: 10/22/2018 - CME EXPIRED: 10/22/2020